Yu Y - Search Results

1

Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis.

Wang Y, Wang L, Guan S, Cao W, Wang H, Chen Z, Zhao Y, Yu Y, Zhang H, Pang JC, Huang SL, Akiyama Y, Yang Y, Sun W, Xu X, Shi Y, Zhang H, Kim ES, Muscal JA, Lu F, Yang J. Wang Y, et al. Among authors: yu y. Sci Rep. 2016 Jan 20;6:19423. doi: 10.1038/srep19423. Sci Rep. 2016. PMID: 26786851 Free PMC article.

2

Lys63-linked polyubiquitination of BRAF at lysine 578 is required for BRAF-mediated signaling.

An L, Jia W, Yu Y, Zou N, Liang L, Zhao Y, Fan Y, Cheng J, Shi Z, Xu G, Li G, Yang J, Zhang H. An L, et al. Among authors: yu y. Sci Rep. 2013;3:2344. doi: 10.1038/srep02344. Sci Rep. 2013. PMID: 23907581 Free PMC article.

3

mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling.

Zhang H, Dou J, Yu Y, Zhao Y, Fan Y, Cheng J, Xu X, Liu W, Guan S, Chen Z, shi Y, Patel R, Vasudevan SA, Zage PE, Zhang H, Nuchtern JG, Kim ES, Fu S, Yang J. Zhang H, et al. Among authors: yu y. Apoptosis. 2015 Jan;20(1):50-62. doi: 10.1007/s10495-014-1066-0. Apoptosis. 2015. PMID: 25425103 Free PMC article.

4

Next-generation proteasome inhibitor MLN9708 sensitizes breast cancer cells to doxorubicin-induced apoptosis.

Wang H, Yu Y, Jiang Z, Cao WM, Wang Z, Dou J, Zhao Y, Cui Y, Zhang H. Wang H, et al. Among authors: yu y. Sci Rep. 2016 May 24;6:26456. doi: 10.1038/srep26456. Sci Rep. 2016. PMID: 27217076 Free PMC article.

5

Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity.

Chen Z, Wang Z, Pang JC, Yu Y, Bieerkehazhi S, Lu J, Hu T, Zhao Y, Xu X, Zhang H, Yi JS, Liu S, Yang J. Chen Z, et al. Among authors: yu y. Sci Rep. 2016 Jul 5;6:29090. doi: 10.1038/srep29090. Sci Rep. 2016. PMID: 27378523 Free PMC article.

6

Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth in vivo.

Li H, Wang Y, Chen Z, Lu J, Pan J, Yu Y, Zhao Y, Zhang H, Hu T, Liu Q, Yang J. Li H, et al. Among authors: yu y. Oncotarget. 2017 Jan 24;8(4):5874-5884. doi: 10.18632/oncotarget.11580. Oncotarget. 2017. PMID: 27564113 Free PMC article.

7

TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells.

Wang Z, Zhang H, Shi M, Yu Y, Wang H, Cao WM, Zhao Y, Zhang H. Wang Z, et al. Among authors: yu y. Sci Rep. 2016 Sep 7;6:32737. doi: 10.1038/srep32737. Sci Rep. 2016. PMID: 27599572 Free PMC article.

8

Novel proteasome inhibitor ixazomib sensitizes neuroblastoma cells to doxorubicin treatment.

Li H, Chen Z, Hu T, Wang L, Yu Y, Zhao Y, Sun W, Guan S, Pang JC, Woodfield SE, Liu Q, Yang J. Li H, et al. Among authors: yu y. Sci Rep. 2016 Sep 30;6:34397. doi: 10.1038/srep34397. Sci Rep. 2016. PMID: 27687684 Free PMC article.

9

Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis.

Guan S, Zhao Y, Lu J, Yu Y, Sun W, Mao X, Chen Z, Xu X, Pan J, Sun S, Yang J. Guan S, et al. Among authors: yu y. Oncotarget. 2016 Nov 15;7(46):75914-75925. doi: 10.18632/oncotarget.12427. Oncotarget. 2016. PMID: 27713150 Free PMC article.

10

Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma.

Lu J, Guan S, Zhao Y, Yu Y, Wang Y, Shi Y, Mao X, Yang KL, Sun W, Xu X, Yi JS, Yang T, Yang J, Nuchtern JG. Lu J, et al. Among authors: yu y. Oncotarget. 2016 Dec 13;7(50):82757-82769. doi: 10.18632/oncotarget.12634. Oncotarget. 2016. PMID: 27764791 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,295 results

Search Page

Filters